153 related articles for article (PubMed ID: 38412593)
1. Hormone replacement therapy and breast cancer incidence in Korean women.
Choi E; Lee JK; Baek JK; Chung Y; Kim H; Yun BH; Seo SK
Maturitas; 2024 May; 183():107946. PubMed ID: 38412593
[TBL] [Abstract][Full Text] [Related]
2. Is breast cancer risk the same for all progestogens?
Stute P
Arch Gynecol Obstet; 2014 Aug; 290(2):207-9. PubMed ID: 24838289
[TBL] [Abstract][Full Text] [Related]
3. Relationship between menopausal hormone therapy and incidence of fractures in postmenopausal women.
Kim H; Kang MJ; Baek JK; Lee JK; Choi EA; Yun BH; Kim EH; Seo SK
Climacteric; 2024 Apr; 27(2):165-170. PubMed ID: 37947171
[TBL] [Abstract][Full Text] [Related]
4. Use of postmenopausal hormone therapies and risk of histology- and hormone receptor-defined breast cancer: results from a 15-year prospective analysis of NIH-AARP cohort.
Wang SM; Pfeiffer RM; Gierach GL; Falk RT
Breast Cancer Res; 2020 Nov; 22(1):129. PubMed ID: 33239054
[TBL] [Abstract][Full Text] [Related]
5. Race, Menopausal Hormone Therapy, and Invasive Breast Cancer in the Carolina Breast Cancer Study.
DeBono NL; Robinson WR; Lund JL; Tse CK; Moorman PG; Olshan AF; Troester MA
J Womens Health (Larchmt); 2018 Mar; 27(3):377-386. PubMed ID: 28570827
[TBL] [Abstract][Full Text] [Related]
6. Menopausal hormone therapy and breast cancer.
Santen RJ
J Steroid Biochem Mol Biol; 2014 Jul; 142():52-61. PubMed ID: 23871991
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer risk association with postmenopausal hormone therapy: Health Insurance Database in South Korea-based cohort study.
Yuk JS; Kim T; Cho H; Gwak G
Eur J Endocrinol; 2024 Jan; 190(1):1-11. PubMed ID: 38128117
[TBL] [Abstract][Full Text] [Related]
8. The breast cancer "plunge" after initial publication of the WHI results: an alternative explanation.
Simon JA; Nahum GG; Stanislaw H; Gaines T
Maturitas; 2010 Jul; 66(3):277-84. PubMed ID: 20471761
[TBL] [Abstract][Full Text] [Related]
9. The Women's Health Initiative randomized trials of menopausal hormone therapy and breast cancer: findings in context.
Chlebowski RT; Aragaki AK
Menopause; 2023 Apr; 30(4):454-461. PubMed ID: 36727752
[TBL] [Abstract][Full Text] [Related]
10. Menopausal hormone therapy use in relation to breast cancer incidence in 11 European countries.
Antoine C; Ameye L; Paesmans M; de Azambuja E; Rozenberg S
Maturitas; 2016 Feb; 84():81-8. PubMed ID: 26654400
[TBL] [Abstract][Full Text] [Related]
11. Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause.
Davey DA
Womens Health (Lond); 2012 Mar; 8(2):169-89. PubMed ID: 22375720
[TBL] [Abstract][Full Text] [Related]
12. Relationship between the type of hormone replacement therapy and incidence of breast cancer in Korea.
Baek JK; Kim HI; Kang MJ; Seon KE; Kim EH; Seo SK
Climacteric; 2022 Oct; 25(5):516-522. PubMed ID: 35674251
[TBL] [Abstract][Full Text] [Related]
13. Menopausal hormone therapy and women's health: An umbrella review.
Zhang GQ; Chen JL; Luo Y; Mathur MB; Anagnostis P; Nurmatov U; Talibov M; Zhang J; Hawrylowicz CM; Lumsden MA; Critchley H; Sheikh A; Lundbäck B; Lässer C; Kankaanranta H; Lee SH; Nwaru BI
PLoS Med; 2021 Aug; 18(8):e1003731. PubMed ID: 34339416
[TBL] [Abstract][Full Text] [Related]
14. Association between menopausal hormone therapy and the risk of gastric cancer: A Korean nationwide population-based cohort study.
Han KH; Choi YJ; Han K; Shin CM; Park NH; Lee DH
Maturitas; 2024 Jun; 184():107960. PubMed ID: 38460415
[TBL] [Abstract][Full Text] [Related]
15. Menopausal hormone therapy and risk of breast cancer: a meta-analysis of epidemiological studies and randomized controlled trials.
Greiser CM; Greiser EM; Dören M
Hum Reprod Update; 2005; 11(6):561-73. PubMed ID: 16150812
[TBL] [Abstract][Full Text] [Related]
16. Menopausal hormone therapy and cancer risk: An overestimated risk?
Simin J; Tamimi R; Lagergren J; Adami HO; Brusselaers N
Eur J Cancer; 2017 Oct; 84():60-68. PubMed ID: 28783542
[TBL] [Abstract][Full Text] [Related]
17. Changing concepts: Menopausal hormone therapy and breast cancer.
Chlebowski RT; Anderson GL
J Natl Cancer Inst; 2012 Apr; 104(7):517-27. PubMed ID: 22427684
[TBL] [Abstract][Full Text] [Related]
18. Estrogen-progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks?
Fournier A; Mesrine S; Boutron-Ruault MC; Clavel-Chapelon F
J Clin Oncol; 2009 Nov; 27(31):5138-43. PubMed ID: 19752341
[TBL] [Abstract][Full Text] [Related]
19. Menopausal hormone therapy and the risk of type 2 diabetes mellitus: Health Insurance Database in South Korea-based retrospective cohort study.
Yuk JS; Kim JM
Menopause; 2023 May; 30(5):497-505. PubMed ID: 36917757
[TBL] [Abstract][Full Text] [Related]
20. Systemic or Vaginal Hormone Therapy After Early Breast Cancer: A Danish Observational Cohort Study.
Cold S; Cold F; Jensen MB; Cronin-Fenton D; Christiansen P; Ejlertsen B
J Natl Cancer Inst; 2022 Oct; 114(10):1347-1354. PubMed ID: 35854422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
